Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Intercell Taking Iomai In $189M Deal

12 May 2008

• By Randall Osborne

Vaccine-patch technology includes product headed for Phase III.

Related Content

Merck To Test Iomai’s Vaccine Booster Patch

03 Apr 2008

Intercell Japanese Encephalitis Vaccine May Launch In 2007

25 Aug 2006

Novartis Vaccines Portfolio Gets A Boost With Access To Intercell Technology

02 Jul 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.